Ultra-hypofractionated Radiotherapy in Breast Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

July 21, 2021

Primary Completion Date

July 21, 2023

Study Completion Date

July 21, 2026

Conditions
Female Breast Cancer
Interventions
RADIATION

ultra-hypofractionated whole breast irradiation

"All enrolled patients will be treated with an ultra-ipofractionated whole breast irradiation schedule (26 Gy delivered in 5 consecutive fractions, single dose 5.2 Gy), according to FAST-Forward trial. Whole bresat irradiation should be followed or not by a tumor bed boost (sequential: 7.6 Gy in 2 consecutive fractions, single dose 3.8 Gy or simultaneous intergrated boost: 30 Gy in 5 consecutive fractions, single dose 6 Gy). Either three-dimensional conformal radiotherapy (3DCRT), intensity-modulated radiotherapy (IMRT), volumetric modulated arc therapy (VMAT) or helicoildal techniques are allowed. Breath control techniques may be used at the discretion of each partecipating centre.~Main exclusion critereria are mastectomy and regional nodal irradiation. Neoadjuvant and/or adjuvant systemic therapies are allowed."

Trial Locations (1)

06132

RECRUITING

Radiation Oncology Section, Department of Medicine and Surgery, University of Perugia, Perugia

All Listed Sponsors
lead

University Of Perugia

OTHER